New drug application (NDA)

The formal process through which a company or other body requests permission from the US Food and Drug Administration (FDA) to make and sell a drug in the USA. In Europe, the equivalent process is known as a marketing authorization application (MAA).

New Drug Application (FDA, 2019)

Marketing authorisation (EMA, 2020)